Browsing by Author Bruix Tudó, Jordi

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 13 to 20 of 20 < previous 
Issue DateTitleAuthor(s)
1-Jun-2018Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trialPinyol, Roser; Montal, Robert; Bassaganyas, Laia; Sia, Daniela; Takayama, Tadatoshi; Chau, Gar-Yang; Mazzaferro, Vincenzo; Roayaie, Sasan; Lee, Han Chu; Kokudo, Norihiro; Zhang, Zhongyang; Torrecilla, Sara; Moeini, Agrin; Rodriguez-Carunchio, Leonardo; Gane, Edward; Verslype, Chris; Croitoru, Adina Emilia; Cillo, Umberto; de la Mata, Manuel; Lupo, Luigi; Strasser, Simone; Park, Joong-Won; Camps, Jordi; Solé, Manel; Thung, Swan N.; Villanueva, Augusto; Pena, Carol; Meinhardt, Gerold; Bruix Tudó, Jordi; Llovet i Bayer, Josep Maria
15-Nov-2017Pilot study of living donor liver transplantation for patients with HCC exceeding Milan criteriaLlovet i Bayer, Josep Maria; Pavel, Mihai; Rimola, Jordi; Diaz, Maria Alba; Colmenero, Jordi; Saavedra Pérez, David; Fondevila Campo, Constantino; Ayuso Colella, Carmen; Fuster Obregón, Josep; Ginès i Gibert, Pere; Bruix Tudó, Jordi; García-Valdecasas Salgado, Juan Carlos
17-Dec-2020Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practiceRimola, Jordi; Da Fonseca, Leonardo G.; Sapena, Victor; Perelló, Chistie; Guerrero, Antonio; Torner Simó, Maria; Pons, Mònica; De la Torre Aláez, Manuel; Calleja Panero, José Luis; Lledó, José L.; Varela, Maria; Mínguez, Beatriz; Sangro, Bruno; Matilla, Ana; Torres, Ferran; Ayuso Colella, Carmen; Bruix Tudó, Jordi; Reig, María; Márquez, Laura
1-Feb-2020Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma ModelsCucarull, Blanca; Tutusaus, Anna; Subias, Miguel; Tutusaus, Anna; Hernáez Alsina, Tania; Boix i Ferrero, Loreto; Reig, María; García de Frutos, Pablo; Marí García, Montserrat; Colell Riera, Anna; Bruix Tudó, Jordi; Morales Muñoz, Albert
1-Nov-2016Restoring mir122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through smad-independent TGF-β pathway.Boix i Ferrero, Loreto; López-Oliva, Juan Manuel; Rhodes Cabrerizo, Ana Carolina; Bruix Tudó, Jordi
20-Feb-2014Search: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinomaZhu, Andrew X.; Rosmorduc, Olivier; Evans, T.R. Jeffry; Ross, Paul J.; Santoro, Armando; Carrilho, Flair José; Bruix Tudó, Jordi; Qin, Shukui; Thuluvath, Paul J.; Llovet i Bayer, Josep Maria; Leberre, Marie-Aude; Jensen, Markus; Meinhardt, Gerold; Kang, Yoon-Koo
11-Dec-2014Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancerBarbier Torres, Lucía; Delgado, Teresa C.; García Rodríguez, Juan L.; Zubiete Franco, Imanol; Fernández Ramos, David; Buqué, Xabier; Cano, Ainara; Gutiérrez de Juan, Virginia; Fernández Domínguez, Itziar; Lopitz Otsoa, Fernando; Fernández Tussy, Pablo; Boix i Ferrero, Loreto; Bruix Tudó, Jordi; Villa, Erica; Castro, Azucena; Lu, Shelly C.; Aspichueta, Patricia; Xirodimas, Dimitris; Varela Rey, Marta; Mato, José M.; Beraza, Naiara; Martínez Chantar, Maria Luz
21-Jun-1994Tractament del carcinoma hepatocel·lular avançat mitjançant embolització de l'artèria hepàticaCastells Garangou, Antoni